Literature DB >> 15735682

HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas.

Michael J Gray1, Jing Zhang, Lee M Ellis, Gregg L Semenza, Douglas B Evans, Stephanie S Watowich, Gary E Gallick.   

Abstract

Hypoxia stimulates a number of pathways critical to cancer cell survival, including the activation of vascular endothelial growth factor (VEGF) transcription. In normal fibroblasts, hypoxia-induced activation of the protein tyrosine kinase, Src, is required for VEGF expression. We show here in both pancreatic and prostate carcinoma cell lines cobalt chloride (used to mimic hypoxia) -induced VEGF expression requires Src activation and leads to increased steady-state levels of HIF-1alpha and increased phosphorylation of signal and transducer of transcription 3 (STAT3). STAT3 and hypoxia-inducible factor (HIF)-1alpha bind simultaneously to the VEGF promoter, where they form a molecular complex with the transcription coactivators CBP/p300 and Ref-1/APE. Expression of activated Src from an inducible promoter is sufficient to increase VEGF expression and form these STAT3/HIF-1alpha-containing promoter complexes. Inhibition of DNA binding by expression of either STAT3 or HIF-1alpha dominant negative mutants significantly reduces VEGF expression. These data suggest that the binding of both STAT3 and HIF-1alpha to the VEGF promoter is required for maximum transcription of VEGF mRNA following hypoxia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15735682     DOI: 10.1038/sj.onc.1208513

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  148 in total

1.  Nature versus nurture in glioblastoma: microenvironment and genetics can both drive mesenchymal transcriptional signature.

Authors:  Brent A Orr; Charles G Eberhart
Journal:  Am J Pathol       Date:  2012-03-23       Impact factor: 4.307

Review 2.  Nonreceptor tyrosine kinases in prostate cancer.

Authors:  Yu-Ming Chang; Hsing-Jien Kung; Christopher P Evans
Journal:  Neoplasia       Date:  2007-02       Impact factor: 5.715

3.  A phase II trial of dasatinib in patients with metastatic castration-resistant prostate cancer treated previously with chemotherapy.

Authors:  Przemyslaw W Twardowski; Jan H Beumer; C S Chen; Andrew S Kraft; Gurkamal S Chatta; Masato Mitsuhashi; Wei Ye; Susan M Christner; Michael B Lilly
Journal:  Anticancer Drugs       Date:  2013-08       Impact factor: 2.248

4.  Apurinic/apyrimidinic endonuclease-1 is associated with angiogenesis and VEGF production via upregulation of COX-2 expression in esophageal cancer tissues.

Authors:  Hiroyuki Nagoya; Seiji Futagami; Mayumi Shimpuku; Atsushi Tatsuguchi; Taiga Wakabayashi; Hiroshi Yamawaki; Yasuhiro Kodaka; Tetsuro Kawagoe; Yasuhiko Watarai; Hiroshi Makino; Masao Miyashita; Shinichi Tsuchiya; Sheila E Crowe; Choitsu Sakamoto
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-11-27       Impact factor: 4.052

Review 5.  Src signaling pathways in prostate cancer.

Authors:  Andreas Varkaris; Anastasia D Katsiampoura; John C Araujo; Gary E Gallick; Paul G Corn
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

Review 6.  Targeting SH2 domains in breast cancer.

Authors:  Pietro Morlacchi; Fredika M Robertson; Jim Klostergaard; John S McMurray
Journal:  Future Med Chem       Date:  2014       Impact factor: 3.808

7.  STAT3 inhibitor stattic enhances radiosensitivity in esophageal squamous cell carcinoma.

Authors:  Qu Zhang; Chi Zhang; Jia He; Qing Guo; Desheng Hu; Xi Yang; Jinfeng Wang; Yahui Kang; Ruifang She; Zhongming Wang; Defan Li; Guanhong Huang; Zhaoming Ma; Weidong Mao; Xiaoyi Zhou; Chuangying Xiao; Xinchen Sun; Jianxin Ma
Journal:  Tumour Biol       Date:  2014-12-10

Review 8.  Src family kinases as mediators of endothelial permeability: effects on inflammation and metastasis.

Authors:  M P Kim; S I Park; S Kopetz; G E Gallick
Journal:  Cell Tissue Res       Date:  2008-09-25       Impact factor: 5.249

9.  An Adam15 amplification loop promotes vascular endothelial growth factor-induced ocular neovascularization.

Authors:  Bing Xie; Jikui Shen; Aling Dong; Mara Swaim; Sean F Hackett; Lorenza Wyder; Susanne Worpenberg; Samuel Barbieri; Peter A Campochiaro
Journal:  FASEB J       Date:  2008-04-01       Impact factor: 5.191

10.  Genome-wide analysis and proteomic studies reveal APE1/Ref-1 multifunctional role in mammalian cells.

Authors:  Carlo Vascotto; Laura Cesaratto; Leo A H Zeef; Marta Deganuto; Chiara D'Ambrosio; Andrea Scaloni; Milena Romanello; Giuseppe Damante; Giulio Taglialatela; Daniela Delneri; Mark R Kelley; Sankar Mitra; Franco Quadrifoglio; Gianluca Tell
Journal:  Proteomics       Date:  2009-02       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.